T2 Biosystems EBIT

As of the most recent data (September 2024), TTOO shows a EBIT of $-42M. That compares with $-50M in the prior-year period — up 16.7% year over year. That is below the Industrials sector average of $160B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TTOO's EBIT is now $-42M (was $-50M) — a 16.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether T2 Biosystems is outperforming or lagging.

The Industrials sector average EBIT is about $160B. T2 Biosystems is at $-42M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how TTOO stacks up against individual peers as well.

Tracking TTOO's ebit over time shows whether T2 Biosystems is scaling, shrinking, or reshaping that part of the business. The current reading is $-42M That compares with $-50M in the prior-year period — up 16.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has T2 Biosystems's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-42M) with ownership activity and broader fundamentals.